0 false false false false false false false false false false true false false false false false false No description of principal activity 2022-12-01 Sage Accounts Production Advanced 2023 - FRS102_2023 65,000 65,000 65,000 xbrli:pure xbrli:shares iso4217:GBP 10261876 2022-12-01 2023-11-30 10261876 2023-11-30 10261876 2022-11-30 10261876 2021-12-01 2022-11-30 10261876 2022-11-30 10261876 2021-11-30 10261876 bus:Director1 2022-12-01 2023-11-30 10261876 core:WithinOneYear 2023-11-30 10261876 core:WithinOneYear 2022-11-30 10261876 core:ShareCapital 2023-11-30 10261876 core:ShareCapital 2022-11-30 10261876 core:RetainedEarningsAccumulatedLosses 2023-11-30 10261876 core:RetainedEarningsAccumulatedLosses 2022-11-30 10261876 core:CostValuation core:Non-currentFinancialInstruments 2023-11-30 10261876 core:Non-currentFinancialInstruments 2023-11-30 10261876 core:Non-currentFinancialInstruments 2022-11-30 10261876 bus:SmallEntities 2022-12-01 2023-11-30 10261876 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 10261876 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 10261876 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 10261876 bus:FullAccounts 2022-12-01 2023-11-30
COMPANY REGISTRATION NUMBER: 10261876
Alanduin Ltd
Filleted Unaudited Financial Statements
30 November 2023
Alanduin Ltd
Statement of Financial Position
30 November 2023
2023
2022
Note
£
£
Fixed assets
Investments
4
65,000
65,000
Current assets
Cash at bank and in hand
2,094
21,330
Creditors: amounts falling due within one year
5
71,340
87,994
--------
--------
Net current liabilities
69,246
66,664
--------
--------
Total assets less current liabilities
( 4,246)
( 1,664)
-------
-------
Net liabilities
( 4,246)
( 1,664)
-------
-------
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 4,346)
( 1,764)
-------
-------
Shareholders deficit
( 4,246)
( 1,664)
-------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 16 August 2024 , and are signed on behalf of the board by:
Mr. A Meshiea
Director
Company registration number: 10261876
Alanduin Ltd
Notes to the Financial Statements
Year ended 30 November 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 6 Cambridge Court, 210 Shepherds Bush Road, London, W6 7NJ, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Investments
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Investments
Other investments other than loans
£
Cost
At 1 December 2022 and 30 November 2023
65,000
--------
Impairment
At 1 December 2022 and 30 November 2023
--------
Carrying amount
At 30 November 2023
65,000
--------
At 30 November 2022
65,000
--------
This consist of an equity investment in two companies within the UK.
5. Creditors: amounts falling due within one year
2023
2022
£
£
Other creditors
71,340
87,994
--------
--------
Other creditors include director's loan of £69,308 (2022: £84,308)